Umezawa Naoki, Tsuji Kasumi, Sato Shin, Kikuchi Masaki, Watanabe Hisami, Horai Yuhei, Yamaguchi Masashi, Hisamatsu Yosuke, Umehara Takashi, Higuchi Tsunehiko
Graduate School of Pharmaceutical Sciences, Nagoya City University 3-1 Tanabe-dori, Mizuho-ku Nagoya 467-8603 Japan
Laboratory for Epigenetics Drug Discovery, RIKEN Center for Biosystems Dynamics Research 1-7-22 Suehiro-cho, Tsurumi-ku Yokohama Kanagawa 230-0045 Japan
RSC Adv. 2018 Oct 31;8(64):36895-36902. doi: 10.1039/c8ra07879c. eCollection 2018 Oct 26.
Lysine-specific demethylases 1 and 2 (LSD1 and LSD2) are flavoenzyme demethylases, and their inhibitors are considered as potential chemical tools and anticancer agents. Here we report polyamine-based inhibitors of LSD1 and LSD2. In the initial screening, partially constrained polyamine 2 which contains three -cyclopentane units with a total of six stereogenic centers, showed the most potent LSD1-inhibitory activity. We then prepared a set of optical isomers of 2 and evaluated their inhibitory activities toward LSD1, LSD2, monoamine oxidases A and B (MAO-A and MAO-B). Optical isomers of 2 showed LSD1-inhibitory activity with values of 2.2 to 6.4 μM, and LSD2-inhibitory activity with values of 4.4 to 39 μM; there was a general preference for LSD1 to LSD2. All of them showed weak to negligible inhibition of MAO-A and MAO-B. This selectivity seemed to reflect the differences in the size and shape of the catalytic cavity of target enzymes, and our strategy of employing a set of optical isomers appears to be an effective approach for exploring the structural features of this family of enzymes. Polyamine 9 showed most potent LSD1-inhibitory activity ( = 2.2 μM ), and it also inhibited the proliferation of HL-60 cells (IC = 49 μM). On the other hand, 12 was the most potent inhibitors of LSD2 with values of 4.4 μM.
赖氨酸特异性去甲基化酶1和2(LSD1和LSD2)是黄素酶去甲基化酶,其抑制剂被认为是潜在的化学工具和抗癌剂。在此,我们报道了基于多胺的LSD1和LSD2抑制剂。在初步筛选中,含有三个环戊烷单元且共有六个手性中心的部分受限多胺2表现出最强的LSD1抑制活性。然后我们制备了一组2的光学异构体,并评估了它们对LSD1、LSD2、单胺氧化酶A和B(MAO-A和MAO-B)的抑制活性。2的光学异构体表现出LSD1抑制活性,IC50值为2.2至6.4 μM,以及LSD2抑制活性,IC50值为4.4至39 μM;一般更倾向于抑制LSD1而非LSD2。它们对MAO-A和MAO-B均表现出微弱至可忽略不计的抑制作用。这种选择性似乎反映了靶酶催化腔大小和形状的差异,并且我们采用一组光学异构体的策略似乎是探索该酶家族结构特征的有效方法。多胺9表现出最强的LSD1抑制活性(IC50 = 2.2 μM),并且它还抑制HL-60细胞的增殖(IC50 = 49 μM)。另一方面,12是LSD2的最强抑制剂,IC50值为4.4 μM。